ChemMedChem

Scope & Guideline

Bridging fundamental science and practical medicine.

Introduction

Delve into the academic richness of ChemMedChem with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1860-7179
PublisherWILEY-V C H VERLAG GMBH
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2006 to 2024
AbbreviationCHEMMEDCHEM / ChemMedChem
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPOSTFACH 101161, 69451 WEINHEIM, GERMANY

Aims and Scopes

ChemMedChem focuses on the intersection of chemistry and medicine, emphasizing innovative approaches in drug discovery and development. The journal aims to disseminate research that advances the understanding of medicinal chemistry and its applications in pharmacology and therapeutic interventions.
  1. Medicinal Chemistry and Drug Design:
    The core focus is on the design, synthesis, and evaluation of new chemical entities with potential therapeutic applications, particularly in oncology, infectious diseases, and metabolic disorders.
  2. Biological Evaluation and Mechanistic Studies:
    Research often includes evaluation of biological activities of compounds, exploring mechanisms of action, and understanding structure-activity relationships (SAR) to optimize therapeutic efficacy.
  3. Nanomedicine and Drug Delivery:
    The journal publishes studies on novel drug delivery systems, including nanoparticles and nanocarriers, aimed at enhancing the bioavailability and targeted delivery of therapeutic agents.
  4. Natural Products and Synthetic Derivatives:
    Research related to the isolation, modification, and pharmacological evaluation of natural products and their synthetic derivatives is a prominent theme, highlighting their potential as drug candidates.
  5. Chemical Biology and Target Identification:
    ChemMedChem includes work on the application of chemical tools to elucidate biological pathways, identify drug targets, and develop new therapeutic strategies.
  6. Innovative Analytical Techniques:
    The journal encourages the use of advanced analytical techniques such as molecular modeling, high-throughput screening, and various spectroscopic methods to aid drug discovery.
ChemMedChem has seen a dynamic evolution in its research themes, with several emerging and trending areas that reflect the latest advancements and interests in medicinal chemistry.
  1. Targeted Therapy and Precision Medicine:
    Recent publications highlight a growing interest in targeted therapies and precision medicine approaches, focusing on personalized treatment options based on genetic and biomolecular profiling.
  2. Proteomics and Targeted Protein Degradation:
    The use of proteomics to identify new drug targets and the development of PROTACs (Proteolysis Targeting Chimeras) for targeted protein degradation are gaining traction, showcasing innovative strategies for drug discovery.
  3. Drug Repurposing Strategies:
    There is an increasing trend towards drug repurposing, particularly in the context of emerging diseases such as COVID-19, where existing drugs are evaluated for new therapeutic applications.
  4. Nanotechnology in Therapeutics:
    The integration of nanotechnology in drug delivery systems, including the use of nanomaterials for enhanced therapeutic efficacy and imaging, is a rapidly expanding area of interest.
  5. Artificial Intelligence and Machine Learning in Drug Discovery:
    The application of AI and machine learning techniques for predictive modeling, compound screening, and optimizing drug design processes is becoming increasingly prominent in recent publications.
  6. Hybrid Molecules and Multitarget Agents:
    Research on hybrid molecules that combine multiple pharmacophores or target multiple pathways is on the rise, reflecting a shift towards more complex and effective therapeutic agents.

Declining or Waning

While ChemMedChem continues to thrive in many areas, certain themes have shown a decline in prominence in recent publications. This may reflect shifts in research focus or advancements in related fields.
  1. Traditional Small Molecule Antibiotics:
    Research on traditional small molecule antibiotics has decreased, possibly due to a shift towards exploring novel mechanisms of action and the use of combination therapies to combat antibiotic resistance.
  2. Single-Target Therapeutics:
    The focus on single-target drug design has waned in favor of multitarget approaches, reflecting a growing understanding of the complexity of diseases and the need for holistic treatment strategies.
  3. In vitro Studies without in vivo Validation:
    There is a noticeable decline in standalone in vitro studies that lack in vivo validation, as the field increasingly emphasizes translational research that bridges laboratory findings with clinical relevance.
  4. Basic Chemistry without Biological Context:
    Papers that focus purely on synthetic methodologies without direct applications in medicinal chemistry or biological evaluation have seen a reduction, as the journal prioritizes research with clear therapeutic implications.

Similar Journals

Natural Products Journal

Exploring the Essence of Nature in Health and Healing
Publisher: BENTHAM SCIENCE PUBLISSN: 2210-3155Frequency: 4 issues/year

Natural Products Journal, a leading publication by Bentham Science Publishers, primarily focuses on the rapidly evolving field of Natural Products and their applications in Complementary and Alternative Medicine as well as Drug Discovery. With an ISSN of 2210-3155 and an E-ISSN of 2210-3163, this journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the critical role of natural compounds in health and medicine. Since its inception in 2011, it has consolidated its reputation, achieving a Q3 ranking in Complementary and Alternative Medicine and a Q4 ranking in Drug Discovery as of 2023, illustrating its growing influence within the academic community. Although it currently does not operate as an Open Access journal, it remains a vital resource for cutting-edge research and developments in natural products, offering insightful contributions that pave the way for innovative therapeutic strategies. Located in the Netherlands, the journal is pivotal for those looking to stay at the forefront of research in natural substances and their multifaceted applications.

HETEROCYCLES

Innovative Insights for the Chemistry Community
Publisher: Japan Inst Heterocyclic ChemistryISSN: 0385-5414Frequency: 12 issues/year

HETEROCYCLES, published by the Japan Institute of Heterocyclic Chemistry, stands as a pivotal journal within the fields of Analytical Chemistry, Organic Chemistry, and Pharmacology. With its ISSN 0385-5414 and E-ISSN 1881-0942, HETEROCYCLES has been a respected platform for scholarly work since its establishment in 1983, featuring innovative research up until 2022. While currently not open access, the journal is renowned for its rigorous peer-review process, ensuring the dissemination of high-quality research. Despite its Q4 ranking in the 2023 quartiles for its categories, it plays a crucial role in bridging gaps in knowledge and advancing the discourse on heterocyclic compounds, which are vital in drug discovery and development. Researchers, professionals, and students who are engaged in chemistry and pharmacology will find HETEROCYCLES an essential source of cutting-edge studies, insights, and an opportunity to contribute to the evolving landscape of these scientific fields.

CHEMISTRY LETTERS

Connecting minds through groundbreaking chemical discoveries.
Publisher: CHEMICAL SOC JAPANISSN: 0366-7022Frequency: 12 issues/year

Chemistry Letters, published by the Chemical Society of Japan, is a distinguished academic journal that focuses on pivotal developments in the field of chemistry. Since its inception in 1973, the journal has been a vital platform for the dissemination of novel research findings across various sub-disciplines, encompassing both theoretical advancements and practical applications. As a testament to its significance in the community, Chemistry Letters has achieved a Category Quartile of Q2 in the 2023 ranking for miscellaneous Chemistry journals, reflecting its respected position among peers. Although it does not offer Open Access, the journal remains accessible through institutional subscriptions, thus ensuring a wide reach for its valuable content. With an active scope ranging from general chemistry topics to specialized studies, it is ideal for researchers, professionals, and students alike who seek to contribute to and expand their knowledge within this dynamic field. The journal continuously aims to promote excellence in chemical research, facilitating dialogue and collaboration among chemists worldwide.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Connecting Researchers to the Latest in Medicinal Chemistry.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0223-5234Frequency: 18 issues/year

European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.

TETRAHEDRON LETTERS

Fostering Collaboration in the Chemical Sciences Landscape
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0040-4039Frequency: 52 issues/year

TETRAHEDRON LETTERS, published by Pergamon-Elsevier Science Ltd, is a leading journal in the fields of Biochemistry, Drug Discovery, and Organic Chemistry, with a rich legacy since its inception in 1959. This prestigious journal serves as a vital resource for researchers and professionals dedicated to advancing the understanding of chemical sciences, featuring high-impact research that influences both academic and practical applications. Although it is currently classified in the third quartile across its categories for 2023, its rigorous peer-review process ensures the publication of quality research that contributes to the scientific community. With an ISSN of 0040-4039 and an E-ISSN of 1873-3581, TETRAHEDRON LETTERS is easily accessible for those in the academic landscape seeking to stay abreast of innovative developments. Researchers, professionals, and students alike will find invaluable insights and collaborative opportunities within the pages of TETRAHEDRON LETTERS, making it an essential read for anyone involved in the chemical sciences.

CHEMICAL & PHARMACEUTICAL BULLETIN

Innovating the future of medicine through research and insights.
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0009-2363Frequency: 12 issues/year

CHEMICAL & PHARMACEUTICAL BULLETIN, published by the Pharmaceutical Society of Japan, has been a cornerstone in the fields of chemistry, drug discovery, and medicine since its inception in 1958. With an ISSN of 0009-2363, this esteemed journal offers a platform for the dissemination of innovative research and critical insights contributing to these dynamic disciplines. Housed in Tokyo, Japan, it is strategically poised to bridge the gap between chemical sciences and pharmaceutical applications. Although the journal operates under a traditional subscription model and does not currently offer open access, it maintains a solid reputation, evidenced by its Q3 category rankings in multiple relevant fields and its percentile positions in Scopus, specifically 48th in General Chemistry and 30th in Drug Discovery. Researchers, professionals, and students alike will find invaluable resources within its pages, as it diligently covers shifting paradigms and emerging methodologies critical to advancing both theoretical understanding and practical applications in the pharmaceutical realm.

Records of Natural Products

Advancing Discoveries in Natural Product Science
Publisher: ACG PUBLICATIONSISSN: 1307-6167Frequency: 6 issues/year

Records of Natural Products is a distinguished journal focused on the dynamic fields of Drug Discovery, Organic Chemistry, Pharmacology, and Plant Science. Published by ACG PUBLICATIONS in Turkey, this journal serves as a vital platform for disseminating innovative research findings and advancements in natural product studies. With its convergence spanning from 2009 to 2024, Records of Natural Products holds a commendable position in the academic realm, featuring a 2023 Q3 ranking in Drug Discovery and Organic Chemistry, alongside a notable Q2 ranking in Plant Science. Despite its current lack of open access, the journal is committed to providing quality content that enriches the understanding of natural products and their potential applications. Researchers and professionals alike can benefit from the journal's insights, which not only contribute to scientific knowledge but also facilitate advancements in pharmaceuticals and sustainable practices. By exploring the rich tapestry of natural product research, this journal underscores its importance as a leading resource for professionals dedicated to enhancing the efficacy and application of natural compounds.

Open Chemistry

Empowering the Global Chemistry Community Through Open Research
Publisher: DE GRUYTER POLAND SP Z O OISSN: 2391-5420Frequency: 1 issue/year

Open Chemistry, published by DE GRUYTER POLAND SP Z O O, is a distinguished peer-reviewed journal that has been serving the global chemistry community since its inception. With an ISSN of 2391-5420 and an E-ISSN also of 2391-5420, this open-access journal has been accessible to researchers and practitioners alike since 2015, ensuring a wide dissemination of high-quality research findings. Located in Germany, specifically at BOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND, Open Chemistry aims to publish innovative research across various chemical disciplines, with special attention to miscellaneous chemistry and materials chemistry. It is currently ranked in the Q3 category for both fields as of 2023, reflecting its solid standing within the academic community, with specific ranks of 187/408 in General Chemistry and 153/317 in Materials Chemistry, corresponding to respective percentiles of 54 and 51. Open Chemistry not only enhances the accessibility of cutting-edge research but also serves as a vital resource for students, professionals, and scholars seeking to advance their knowledge in the rapidly evolving landscape of chemical sciences.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Exploring breakthroughs in bioorganic science.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-894XFrequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading journal in the fields of biochemistry, drug discovery, and medicinal chemistry, designed to disseminate significant advances in these disciplines. Established in 1991, the journal spans various important categories, including Organic Chemistry and Pharmaceutical Science, with its 2023 Scimago Journal Rank placing it at Q2 in Organic Chemistry and Q3 in several other relevant fields. Though not an open-access publication, it provides invaluable insights into contemporary research and innovative methodologies, appealing to researchers, professionals, and students alike. The journal's commitment to quality and relevance makes it a vital resource for those aiming to stay at the forefront of bioorganic and medicinal chemistry developments. For more information, please visit the journal's website as it remains a critical platform for scholarly exchange, particularly for those engaged in interdisciplinary research.

BIOORGANIC CHEMISTRY

Exploring innovative pathways in drug discovery.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0045-2068Frequency: 12 issues/year

BIOORGANIC CHEMISTRY, published by Academic Press Inc., a prestigious imprint of Elsevier Science, represents a cornerstone in the fields of biochemistry, organic chemistry, and drug discovery. With an impressive Scopus rank placing it in the top quartiles across critical categories—including Q2 for Biochemistry and Drug Discovery, and Q1 for Organic Chemistry—this journal has established itself as a vital resource for researchers, professionals, and students alike. Featuring a diverse array of articles that explore innovative methodologies and emerging trends from 1971 to the present, BIOORGANIC CHEMISTRY effectively bridges the gap between laboratory research and practical applications. Although not an Open Access journal, its rigorous peer-review process ensures the delivery of high-quality, impactful research that drives advances in the understanding and application of biochemistry. With an aim to facilitate scientific discourse and collaboration, it invites contributions that further the exploration of chemical processes within biological systems.